Biktarvy, formally known as biktarvy, represents a potent single-tablet therapy for treating HIV infection. This formula combines three crucial antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by inhibiting the the viral ability to replicate within the body, considerably decreasing the viral quantity. For many